Ono Pharmaceutical has a total of 4586 patents globally, out of which 2051 have been granted. Of these 4586 patents, more than 31% patents are active. Japan is where Ono Pharmaceutical has filed the maximum number of patents, followed by the United States of America and Europe. Parallelly, Japan seems to be the main focused R&D centre and also is the origin country of Ono Pharmaceutical.
Ono Pharmaceutical was founded in the year 1717. The Company manufactures and sells pharmaceutical products. The Company mainly researches and develops prescription drugs. As of March 2023, the market cap of Ono Pharmaceutical is $10.24 Billion.
Do read about some of the most popular patents of Ono Pharmaceutical which have been covered by us in this article and also you can find Ono Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ono Pharmaceutical patent portfolio.
How many patents does the founder and the CEO of Ono Pharmaceutical have?
The founder Ichibei Ono has 0 patent and CEO Gyo Sagara has 0 patent.
How many patents does Ono Pharmaceutical have?
Ono Pharmaceutical has a total of 4586 patents globally. These patents belong to 929 unique patent families. Out of 4586 patents, 1467 patents are active.
How Many Patents did Ono Pharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Ono Pharmaceutical Applications Filed | Ono Pharmaceutical Patents Granted |
| 2023 | – | 9 |
| 2022 | 38 | 76 |
| 2021 | 105 | 86 |
| 2020 | 160 | 107 |
| 2019 | 186 | 131 |
| 2018 | 129 | 107 |
| 2017 | 163 | 141 |
| 2016 | 179 | 117 |
| 2015 | 168 | 98 |
| 2014 | 206 | 108 |
| 2013 | 131 | 119 |
| 2012 | 191 | 114 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How many Ono Pharmaceutical patents are Alive/Dead?
How Many Patents did Ono Pharmaceutical File in Different Countries?
Countries in which Ono Pharmaceutical Filed Patents
| Country | Patents |
| Japan | 658 |
| United States Of America | 546 |
| Europe | 414 |
| Australia | 202 |
| Korea (South) | 188 |
| Germany | 174 |
| Taiwan | 154 |
| China | 140 |
| Spain | 132 |
| Canada | 114 |
| Mexico | 114 |
| Brazil | 111 |
| Russia | 109 |
| South Africa | 104 |
| Israel | 84 |
| Norway | 83 |
| India | 81 |
| New Zealand | 77 |
| Denmark | 65 |
| Austria | 64 |
| Portugal | 62 |
| Hungary | 61 |
| Hong Kong (S.A.R.) | 60 |
| Singapore | 57 |
| Poland | 54 |
| Indonesia | 49 |
| Viet Nam | 48 |
| Philippines | 40 |
| Malaysia | 39 |
| Macao | 18 |
| Italy | 18 |
| Turkey | 11 |
| Czech Republic | 10 |
| Argentina | 6 |
| Malta | 5 |
| Morocco | 5 |
| Lithuania | 4 |
| Slovenia | 4 |
| United Kingdom | 4 |
| Peru | 4 |
| Cyprus | 3 |
| Luxembourg | 3 |
| Chile | 3 |
| Albania | 2 |
| San Marino | 2 |
| Iceland | 2 |
| Ecuador | 2 |
| Dominican Republic | 2 |
| Croatia | 2 |
| Serbia | 2 |
| Jordan | 1 |
| Eurasia | 1 |
| Africa | 1 |
| Bolivia | 1 |
| Brunei | 1 |
| Uruguay | 1 |
Where are the Research Centres of Ono Pharmaceutical Patents Located?
10 Best Ono Pharmaceutical Patents
WO2006121168A1 is the most popular patent in the Ono Pharmaceutical portfolio. It has received 2326 citations so far from companies like Genentech, Amplimmune, and Novartis.
Below is the list of 10 most cited patents of Ono Pharmaceutical:
| Publication Number | Citation Count |
| WO2006121168A1 | 2326 |
| WO2004004771A1 | 783 |
| US7595048B2 | 513 |
| WO2004072286A1 | 444 |
| US8168179B2 | 409 |
| WO2004026873A1 | 314 |
| US8728474B2 | 287 |
| US20020193567A1 | 271 |
| US20060004010A1 | 209 |
| US9073994B2 | 200 |
How many inventions of other companies were rejected due to Ono Pharmaceutical patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Ono Pharmaceutical invention. They couldn’t because Ono Pharmaceutical had protected those before them.
Examiners at the USPTO referred 94 Ono Pharmaceutical patents in 289 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Ono Pharmaceutical patent portfolio are National Institutes Of Health, Wellesley Pharmaceuticals and Novartis.
List of the Companies whose Patents were rejected citing Ono Pharmaceutical –
| Company | Number of Patent Applications that faced Rejection Citing Ono Pharmaceutical Patents | Number of Rejections (102 & 103) |
| National Institutes Of Health | 4 | 6 |
| Wellesley Pharmaceuticals | 4 | 6 |
| Novartis | 4 | 9 |
| Allergan | 4 | 4 |
| Merck Sharp & Dohme | 4 | 4 |
| Omeros Corporation | 3 | 7 |
| Ganymed Pharmaceuticals | 3 | 4 |
| Yale University | 2 | 3 |
| Pharmacyclics | 2 | 6 |
| Osaka University | 2 | 4 |
Count of 102 and 103 Type Rejections based on Ono Pharmaceutical Patents
Top Ono Pharmaceutical Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US7595048B2 | 16 |
| US8460886B2 | 5 |
| US7968572B2 | 5 |
| US7378428B2 | 4 |
| US20020065394A1 | 4 |
| US20080057115A1 | 4 |
| US8728474B2 | 4 |
| US7288558B2 | 4 |
| US6624193B1 | 3 |
| US20050119305A1 | 3 |
| US7491748B2 | 3 |
| US8575134B2 | 3 |
| US7344861B2 | 3 |
| US7151093B2 | 3 |
| US20020086364A1 | 2 |
What Percentage of Ono Pharmaceutical US Patent Applications were Granted?
Ono Pharmaceutical (Excluding its subsidiaries) has filed 466 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 293 have been granted leading to a grant rate of 68.14%.
Below are the key stats of Ono Pharmaceutical patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Ono Pharmaceutical?
| Law Firm | Total Applications | Success Rate |
| Sughrue 265550 | 180 | 66.03% |
| Sughrue Mion | 65 | 42.86% |
| Sughrue Mion Zinn Macpeak & Seas | 39 | 82.05% |
| Stevens Davis Miller & Mosher | 24 | 73.91% |
| Wenderoth Lind & Ponack | 21 | 63.16% |
| Sterne Kessler Goldstein & Fox | 17 | 93.75% |
| Foley & Lardner | 14 | 84.62% |
| Cpa Global | 10 | 100.00% |
| Millen White Zelano & Branigan | 7 | 71.43% |
| Sughrue Mion Zinn | 7 | 50.00% |